528 related articles for article (PubMed ID: 38045830)
1. Biomarkers and experimental models for cancer immunology investigation.
Xu H; Jia Z; Liu F; Li J; Huang Y; Jiang Y; Pu P; Shang T; Tang P; Zhou Y; Yang Y; Su J; Liu J
MedComm (2020); 2023 Dec; 4(6):e437. PubMed ID: 38045830
[TBL] [Abstract][Full Text] [Related]
2. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment.
Zhang J; Tavakoli H; Ma L; Li X; Han L; Li X
Adv Drug Deliv Rev; 2022 Aug; 187():114365. PubMed ID: 35667465
[TBL] [Abstract][Full Text] [Related]
4. Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts.
Capasso A; Lang J; Pitts TM; Jordan KR; Lieu CH; Davis SL; Diamond JR; Kopetz S; Barbee J; Peterson J; Freed BM; Yacob BW; Bagby SM; Messersmith WA; Slansky JE; Pelanda R; Eckhardt SG
J Immunother Cancer; 2019 Feb; 7(1):37. PubMed ID: 30736857
[TBL] [Abstract][Full Text] [Related]
5. [Advances in three-dimensional tumor models for colorectal cancer].
Wang CT; Zhou JL; Lin GL; Yin SY; Cong L; Zhang GN; An Y; Qiu XY
Zhonghua Zhong Liu Za Zhi; 2023 Jun; 45(6):464-470. PubMed ID: 37355464
[TBL] [Abstract][Full Text] [Related]
6. Modeling Tumor Immunology and Immunotherapy in Mice.
Buqué A; Galluzzi L
Trends Cancer; 2018 Sep; 4(9):599-601. PubMed ID: 30149876
[TBL] [Abstract][Full Text] [Related]
7. Establishment of humanized tumor microenvironment mouse models based on the injection of peripheral blood mononuclear cells and IFN-γ to evaluate the efficacy of PD-L1/PD-1-targeted immunotherapy.
Lin X; Zeng T; Lin J; Zhang Q; Cheng H; Fang S; Lin S; Chen Y; Xu Y; Lin J
Cancer Biol Ther; 2020; 21(2):130-138. PubMed ID: 31690181
[TBL] [Abstract][Full Text] [Related]
8. Understanding and improving cellular immunotherapies against cancer: From cell-manufacturing to tumor-immune models.
Ringquist R; Ghoshal D; Jain R; Roy K
Adv Drug Deliv Rev; 2021 Dec; 179():114003. PubMed ID: 34653533
[TBL] [Abstract][Full Text] [Related]
9. 3D Culture Systems for Exploring Cancer Immunology.
Fitzgerald AA; Li E; Weiner LM
Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33379189
[TBL] [Abstract][Full Text] [Related]
10. In Vitro and In Vivo Tumor Models for the Evaluation of Anticancer Nanoparticles.
Abreu TR; Biscaia M; Gonçalves N; Fonseca NA; Moreira JN
Adv Exp Med Biol; 2021; 1295():271-299. PubMed ID: 33543464
[TBL] [Abstract][Full Text] [Related]
11. Immune Infiltrates in Breast Cancer: Recent Updates and Clinical Implications.
Dieci MV; Miglietta F; Guarneri V
Cells; 2021 Jan; 10(2):. PubMed ID: 33498711
[TBL] [Abstract][Full Text] [Related]
12. Opportunities and challenges to engineer 3D models of tumor-adaptive immune interactions.
Visalakshan RM; Lowrey MK; Sousa MGC; Helms HR; Samiea A; Schutt CE; Moreau JM; Bertassoni LE
Front Immunol; 2023; 14():1162905. PubMed ID: 37081897
[TBL] [Abstract][Full Text] [Related]
13. Progresses in biomarkers for cancer immunotherapy.
Lin X; Zong C; Zhang Z; Fang W; Xu P
MedComm (2020); 2023 Oct; 4(5):e387. PubMed ID: 37799808
[TBL] [Abstract][Full Text] [Related]
14. Biofabrication of 3D breast cancer models for dissecting the cytotoxic response of human T cells expressing engineered MAIT cell receptors.
Dey M; Kim MH; Nagamine M; Karhan E; Kozhaya L; Dogan M; Unutmaz D; Ozbolat IT
Biofabrication; 2022 Sep; 14(4):. PubMed ID: 36108605
[TBL] [Abstract][Full Text] [Related]
15. Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancer.
Lal JC; Townsend MG; Mehta AK; Oliwa M; Miller E; Sotayo A; Cheney E; Mittendorf EA; Letai A; Guerriero JL
Breast Cancer Res; 2021 Aug; 23(1):83. PubMed ID: 34353349
[TBL] [Abstract][Full Text] [Related]
16. Dynamic profiling of immune microenvironment during pancreatic cancer development suggests early intervention and combination strategy of immunotherapy.
Yang J; Zhang Q; Wang J; Lou Y; Hong Z; Wei S; Sun K; Wang J; Chen Y; Sheng J; Su W; Bai X; Liang T
EBioMedicine; 2022 Apr; 78():103958. PubMed ID: 35316682
[TBL] [Abstract][Full Text] [Related]
17. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
[TBL] [Abstract][Full Text] [Related]
18. 3D Tumor Models and Their Use for the Testing of Immunotherapies.
Boucherit N; Gorvel L; Olive D
Front Immunol; 2020; 11():603640. PubMed ID: 33362787
[TBL] [Abstract][Full Text] [Related]
19. Tumor Microenvironment and Hydrogel-Based 3D Cancer Models for In Vitro Testing Immunotherapies.
Vitale C; Marzagalli M; Scaglione S; Dondero A; Bottino C; Castriconi R
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205760
[TBL] [Abstract][Full Text] [Related]
20. Newly developed 3D in vitro models to study tumor-immune interaction.
Mu P; Zhou S; Lv T; Xia F; Shen L; Wan J; Wang Y; Zhang H; Cai S; Peng J; Hua G; Zhang Z
J Exp Clin Cancer Res; 2023 Apr; 42(1):81. PubMed ID: 37016422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
